A detailed history of Veritas Investment Partners (Uk) Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Veritas Investment Partners (Uk) Ltd. holds 2,500 shares of JNJ stock, worth $365,400. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,500
Previous 2,500 -0.0%
Holding current value
$365,400
Previous $391,000 1.02%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $109,151 - $121,107
-700 Reduced 21.88%
2,500 $428,000
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $438,752 - $503,616
3,200 New
3,200 $503,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Veritas Investment Partners (Uk) Ltd. Portfolio

Follow Veritas Investment Partners (Uk) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritas Investment Partners (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Veritas Investment Partners (Uk) Ltd. with notifications on news.